iDNA PGx CNS is a pharmacogenetics test that employs a non-invasive procedure conducted on an oral swab sample. This genetic analysis focuses on identifying specific gene polymorphisms (SNP) that interact with medications, enabling the assessment of drug metabolism, adverse effects, treatment response, and efficacy. The test provides valuable guidance to physicians, helping them tailor treatment options and dosages to each individual patient.

The iDNA PGx CNS analysis serves as a valuable tool for your doctor to make personalized treatment decisions. It assists in determining the most suitable medication and dosage for you, maximizing the likelihood of a favorable response while minimizing the risk of adverse effects.

iDNA PGx CNS was developed for patients suffering from mental or neurological disorders. Pharmacogenetic analysis is indicated in newly diagnosed patients, patients with chronic disease who are not responding to their treatment, and in cases of concomitant use of multiple medications.

The iDNA PGx CNS is a user-friendly and painless test that offers valuable insights into gene-drug interactions. This genetic analysis involves the collection of a sample through the use of an oral swab. The sample is sent to iDNA Laboratories' accredited laboratory, where your DNA is isolated and genotyped. Within a short period of time, you and your doctor receive a comprehensive report detailing your pharmacogenetic analysis.

The oral (buccal) swab contains DNA, which is derived from the cells of the oral cavity tissue. The kit provided includes sterile swabs for sample collection by your doctor or qualified personnel.

Once we receive your sample, our certified laboratory isolates the DNA from the collected cells. Subsequently, iDNA Laboratories utilizes cutting-edge genetic testing methods to analyse your DNA.

There is absolutely no risk from taking the test. Collecting an oral (buccal) swab is simple, quick, and painless.

Human DNA is approximately 99.9% identical from person to person. However, there are small differences that make each individual unique. These differences are called polymorphisms - Single Nucleotide Polymorphism (SNP). Certain variations are associated with distinct traits in individuals, such as drug response and metabolism.

The study of DNA sequencing has uncovered that genes play a direct role in drug metabolism and therapeutic effectiveness for individual patients. Genes are responsible for the significant variability observed in the response of patients with the same disease to the same drug at the same dosage. Additionally, genes can be attributed to the occurrence of avoidable serious adverse effects. Considering that no two individuals or diseases are identical, pharmacogenetics holds the potential to personalize treatment for everyone.

The detailed report of the results is presented in a very understandable way. However, to ensure accurate comprehension of the findings, it is essential for the attending physician to interpret and provide explanations for them.

Pharmacogenetics investigates the interaction between drugs and genes, examining how an individual's genetic profile (DNA) influences their response to medications.

Depending on how the kit is registered (electronically or via paperwork) your treating doctor will be able to access your results via the myEMR platform or via his/her personal email, to receive your results report directly.

In the event you change doctors, you need to contact the company and with proper guidance we will be able to grant access to your results for your new physician.

There is absolutely no risk from taking the test. Collecting an oral (buccal) swab is simple, quick, and painless.

iDNA Cardio Health kit is an in vitro (IVD) diagnostic product, which evaluates, using interpretive software, the genetic analysis of a buccal swab sample, and in combination with phenotypic characteristics (all the morphological characteristics that an organism presents at a given time) assigns an individualized risk of cardiovascular disease using the Polygenic Risk Score (PRS) as well as the Adjusted PRS.

The Polygenic Risk Score (PRS) is a modern genetic profile analysis tool that assesses the probability of vulnerability (predisposition) to a number of cardiovascular diseases.

Adjusted PRS is a unique and innovative method that combines PRS with the current lifestyle and phenotype characteristics of an individual, thus providing the ability to dynamically monitor the risk of developing cardiovascular disease.

The iDNA Cardio health kit aims at early prevention of common cardiovascular diseases as a screening test. The cardiovascular diseases it tests for are:

  • Coronary artery disease
  • Cardiomyopathy (dilated and hypertrophic)
  • Heart failure
  • Arrhythmia (atrial fibrillation)
  • Ischaemic stroke

The iDNA Cardio Health kit can provide information to people who belong to one of 3 groups:

  • Healthy individuals who want to know if they are at risk of developing any of the conditions examined by the test
  • Healthy people with a relative with a cardiac history (positive history) of a condition (Coronary Heart Disease, Heart Failure, Cardiomyopathy (Diastolic and Hypertrophic), Arrhythmia (Atrial Fibrillation), Ischaemic Stroke who have tested negative for hereditary causes.
  • Asymptomatic patients who are either under surveillance or undergoing minimally conservative treatment

iDNA Cardio Health offers you information regarding:

Prevention

-The majority of cardiovascular diseases can be successfully treated thanks to early diagnosis and prevention by creating a personalized prevention plan.

Prevention for your family

-Cardiovascular diseases are largely inherited conditions.

-The results can help relatives to identify potential hereditary risk early and take preventive care of their health

Lifestyle recommendations

-With the lifestyle changes recommended by the treating physician, the impact of predisposition is reduced and optimal health is promoted.

The iDNA Cardio Health kit is designed as an easy and painless test that provides information about your risk of cardiovascular disease. The genetic analysis requires a sample to be taken, painlessly using a swab, from a buccal swab. The sample is then sent to iDNA Laboratories' certified laboratory, where your DNA is isolated and genotyped. Within 20 business days you receive your personalized results report in your personal account on the myEMR online platform.

Genomic Medicine is an emerging scientific field where the clinical care of an individual can be personalized using the results of genetic testing. Specifically, Medical Genetic DNA testing provides information to the physician about health issues such as genetic predisposition to disease and response to medications.

The process to follow is quick and easy. Purchase the iDNA Cardio Health Kit, create an account on the myemr.idna.gr platform, enter the serial number and personal data, fill in the questionnaire and send the buccal swab sample to the iDNA Laboratories.

Within 20 business days you receive the personalized results report in your account within the myEMR online platform.

The detailed report of the results is provided in Greek or English (selected during registration) and the results are presented in a comprehensive way. However, for a better understanding of the results, it is necessary for your doctor to interpret and explain them.